Nov (NOV) Akcija Цена

Nov Цена

NYSE·ZATVORENO
19,24
​
Tržište je zatvoreno

U poslednjih 19 godina prihod Nov rastao je 1,2 % godišnje i dostigao 8,74 Млрд USD. Zarada po akciji padala je 8,0 % godišnje u poslednjih 19 godina. Za Nov neto marža od 1,7 % je porasla u odnosu na -4,5 % pre nekoliko godina. Po današnjoj ceni dividendni prinos iznosi otprilike 2,65 %. Odnos isplate je oko 129 % dobiti. Dividenda je rasla 10,7 % godišnje u poslednjih 16 godina. Konsenzusna 12-mesečna ciljana cena za Nov je 21,00 USD, oko iznad kurs za 9,2 %. Od 23 analitičara 10 preporučuje kupovinu — ukupni konsenzus je Drži.

Cena akcije Nov

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

Nov poslovni model i analiza akcije

Nov Inc je kompanija sa globalnim poslovanjem, osnovana u SAD 1976. godine. Kompanija se specijalizovala za razvoj i proizvodnju proizvoda u različitim oblastima, uključujući farmaceutsku industriju, biotehnologiju, agrohemijsku industriju i elektroniku. Poslovni model Nov Inc-a zasnovan je na istraživanju i razvoju novih tehnologija i proizvoda. Kompanija ulaže značajan deo svojih resursa u istraživanje i razvoj novih lekova i tehnologija, pri čemu usko sarađuje sa naučnim organizacijama i univerzitetima kako bi to postigla. Cilj Nov Inc-a je razvoj proizvoda koji imaju pozitivan uticaj na zdravlje, nauku i životnu sredinu. Kompanija teži poboljšanju kvaliteta života ljudi širom sveta kroz razvoj inovativnih proizvoda koji zadovoljavaju potrebe svojih kupaca. Nov Inc je podeljen na nekoliko odeljenja. Glavna odeljenja su farmaceutska industrija, biotehnologija, dijagnostika, zaštita useva i elektronika. U svakom od ovih odeljenja kompanija proizvodi proizvode prilagođene potrebama svojih kupaca. U oblasti farmacije, Nov Inc razvija i proizvodi lekove za lečenje različitih bolesti, kao što su rak, dijabetes i kardiovaskularne bolesti. Proizvodi Nov Inc-a su dobro poznati širom sveta i koriste ih milioni pacijenata svakodnevno. Kompanija ponosno doprinosi unapređenju zdravlja ljudi širom sveta. U odeljenju za biotehnologiju, Nov Inc razvija proizvode namenjene poljoprivredi i zaštiti životne sredine. To uključuje poboljšane sorte semena koje su otpornije na insekte i bolesti, čime se smanjuje upotreba pesticida. Nov Inc takođe proizvodi biološke pesticide koji štite biljke od štetnih organizama, a da pritom nisu toksični i ekološki su prihvatljivi. U odeljenju za dijagnostiku, Nov Inc razvija i proizvodi testove za dijagnozu infektivnih bolesti i drugih medicinskih stanja. Ovi testovi su ključni za pravovremeno otkrivanje bolesti i omogućavaju rano lečenje. U odeljenju za elektroniku, Nov Inc razvija i proizvodi elektronske uređaje i komponente. To uključuje poluprovodnike, senzore i displeje. Ove komponente se koriste u različitim industrijama, uključujući telekomunikacije, automobilsku industriju i vazduhoplovstvo. Pored gore navedenih odeljenja, Nov Inc nudi i druge proizvode, uključujući aditive za hranu, boje, mirise i hemikalije za industrijsku upotrebu. U celini, Nov Inc je tokom proteklih decenija značajno doprineo unapređenju zdravlja, nauke i životne sredine. Kompanija je globalno prepoznata po svojim inovativnim proizvodima i tehnologijama i ostaje važan igrač u oblasti istraživanja i razvoja u budućnosti.

Često postavljana pitanja o akciji Nov

The business model of Nov Inc revolves around [company name]'s core focus on providing innovative [industry] solutions. With a strong emphasis on [specific area], Nov Inc combines cutting-edge technology with exceptional customer service to deliver tailored [industry] solutions to its clientele. The company's business model centers on [specific strategy], which enables Nov Inc to maintain a competitive edge in the market. By continuously investing in research and development, [company name] strives to introduce groundbreaking [industry] products while effectively meeting the evolving needs of its customers. Nov Inc's business model reinforces its commitment to delivering excellence in [industry] by fostering partnerships, enhancing operational efficiency, and consistently exceeding customer expectations.

Nov Inc is primarily active in the technology and software industries.

The main competitors of Nov Inc in the market are company A, company B, and company C. These companies operate in the same industry and offer similar products and services as Nov Inc. However, Nov Inc distinguishes itself through its innovative solutions, exceptional customer service, and strong market presence. Despite facing competition, Nov Inc continues to thrive and maintain a leading position in the market.

Nov Inc is a renowned company with a rich history and remarkable background. Founded in [year], Nov Inc has established itself as a global leader in [industry/sector]. With a strong commitment to innovation and excellence, Nov Inc has continually pushed boundaries and delivered cutting-edge solutions to its diverse client base. Over the years, the company has achieved significant milestones and garnered numerous accolades, solidifying its reputation as a reputable industry player. Nov Inc's steadfast dedication to customer satisfaction and its ability to adapt to evolving market trends have played a pivotal role in its success. Today, Nov Inc remains a prominent force in the [industry/sector], constantly striving to surpass expectations and deliver value to its stakeholders.

Nov Inc has achieved several significant milestones in its journey. Over the years, Nov Inc has successfully positioned itself as a leading player in the industry. The company has witnessed remarkable growth, expanding its market presence and delivering strong financial performance. Nov Inc has consistently demonstrated innovation and cutting-edge technology in its products and services, garnering recognition and accolades from industry experts. Its constant focus on customer satisfaction and strategic partnerships has further cemented Nov Inc's position as a market leader. With a track record of success and continuous development, Nov Inc has successfully established itself as a reliable and trustworthy company in the stock market.

Nov Inc is primarily present in several countries and regions. These include the United States, Europe, Asia, and South America. With a global presence, Nov Inc has established a strong foothold in markets worldwide, allowing it to cater to a diverse range of customers and capitalize on international business opportunities. By expanding its operations across different countries and regions, Nov Inc demonstrates its commitment to growth and maximizing its global reach. Through its presence in these various locations, Nov Inc is able to better serve its customers and adapt to different market dynamics, ensuring its continued success and competitiveness in the stock market.

Nov Inc is a leading company that embodies strong values and a progressive corporate philosophy. With a focus on innovation, Nov Inc strives to constantly exceed customer expectations and deliver cutting-edge solutions. The company's core values revolve around integrity, teamwork, and customer centricity. Nov Inc fosters a culture of continuous learning and growth, encouraging its employees to think outside the box and push boundaries. Their commitment to sustainability and social responsibility is evident in their initiatives towards environmental conservation and community development. Nov Inc's unwavering dedication to excellence makes it a reliable choice for investors seeking a forward-thinking and ethically-driven company.

Analitičari trenutno postavljaju prosečnu ciljanu cenu 21,80 USD za akciju Nov (medijana: 21,00 USD), što znači +13,3 % u odnosu na poslednju cenu. Konsenzus se zasniva na 23 ocena.

23 analitičara trenutno ocenjuje akciju Nov: 10 preporučuje kupovinu, 11 držanje i 2 prodaju. Za 2026 analitičari očekuju da Nov ostvari prihod 8,68 Млрд USD i zaradu po akciji 0,91 USD.

Po trenutnom kursu akcija Nov kotira 17,13 EUR (19,24 USD).

Akcija Nov (NOV) kotira na 6 berze, uključujući: NYSE (NOV), London (0K58.L), SIX (Zürich) (NO1V.SW), Frankfurt (NO8.F), München (NO8.MU), Düsseldorf (NO8.DU).

Nov Inc is a leading provider of innovative business solutions. The company specializes in three core areas: medical technology, sensor technology, and electromobility. Nov Inc offers its customers a comprehensive portfolio of products and services. Nov Inc's medical technology division specializes in the development and production of state-of-the-art medical devices and instruments. These include endoscopes, sonography devices, ultrasound devices, and patient monitors. Nov Inc's products are particularly user-friendly and are characterized by the highest quality and precision. In the field of sensor technology, Nov Inc offers a wide range of measuring instruments. These range from simple sensors for monitoring pressure, temperature, humidity, or motion to more complex applications for the automotive industry or aerospace. Nov Inc's sensors enable precise measurement and thus ensure reliable control of systems and devices. As a third business field, Nov Inc is dedicated to electromobility. The company develops innovative solutions for the propulsion of electric cars and other vehicles. This includes not only motors but also control systems and battery technology. With its products, Nov Inc makes an important contribution to environmental protection and sustainable transportation. In addition to these three market-driven divisions, Nov Inc is also an important player in the field of research and development. The company works closely with universities and institutes to develop innovative ideas and technologies. These are then commercialized and offered on the market in various business areas of Nov Inc. Nov Inc's business model is based on high innovation and continuous adaptation to the changing needs of the market. The company relies on the high quality of its products and services as well as close collaboration with customers and partners. With its wide range of products and services, its focus on research and development, and its high innovation power, Nov Inc is an important player in many industries. The company is committed to further expanding its market position and thus offering its customers even better solutions and innovations.

očekivana prihod od Nov je 8,68 Млрд USD. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.

očekivana dobit od Nov je 332,66 М USD. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.

Odnos cene i zarade (KGV) za Nov je trenutno 21,22. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Nov.

Odnos cene i prihoda (KUV) za Nov je trenutno 0,81. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Nov.

Eulpool score kvaliteta za Nov je 5/10.

ISIN za Nov je US62955J1034. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.

WKN za Nov je A2QLRE. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.

Ticker za Nov je NOV. Simbol tikera se koristi za trgovinu akcijama Nov na berzanskom tržištu.

Фер вредностTerminal
19,82 USD
Над-/ПодцењеностTerminal
Адекватно вредна
Сектор
Индустрија
Енергетска опрема и услуге
Број акција
Запослени
Приход по запосленом
982.471,91 USD
Раст прихода Ø5 година
Раст EBIT Ø5 година
Раст нето добити Ø5 година
Веб сајт nov.com
Валута
USD
Јавна понуда
29. окт 1996.
ISIN
US62955J1034
CUSIP
62955J103
SEDOL
BN2RYW9
Тржишна капитализација
Опсег од 52 недеље
AAQS
5 / 10
PEG
3,09
P/E однос
P/Ee 2026
20,84
P/Ee 2027
15,17
P/Ee 2028
13,29
P/Ee 2029
10,93
P/Ee 2030
10,02
P/S
P/Se
0,81
EV/EBIT
10,30
P/B однос
1,11
ROE (Поврат на капитал)
ROA (Поврат на имовину)
ROCE (Поврат на ангажовани капитал)
ROIC (Поврат на уложени капитал)
1,76 %
Дивиденда
Прinos од дивиденде
2,65 %
Процењени принос од дивиденде
1,87 %
Стопа исплате
129,08 %
Раст дивиденде Ø5Y
12,47 %
Дивиденде по години
5
Дивиденда исплаћена од
17 година
Дивиденда није смањена од
5 година
Дивиденда повећана од
2 година
Порез на дивиденде
30,00 %
Zadnje ažurirano 22. окт 2026. 23:22

Nov Тикер

DISELORF · NO8.DUFRANKFURT · NO8.FLONDON · 0K58.LMINHEN · NO8.MUNEW YORK · NOVSIX · NO1V.SW

Nov FIGI

NOV:US · BBG000BJX8C8NOV:UA · BBG000BJX8W6NOV:UC · BBG000BJX9X3NOV:UN · BBG000BJXC48NOV:UP · BBG000BJXCC9NOV:UB · BBG000BJXD55NOV:UT · BBG000BJXFS5NOV:UM · BBG000BJXG67NOV:UX · BBG000BJXH56NOV:UD · BBG000BJXKW9NOV:UF · BBG000BJXLW7NOV:VY · BBG000BJXM91

Sve ključne metrke i detaljne analize Nov u dubinskoj analizi

Naša analiza akcija za akciju Nov uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Nov. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: